West Branch Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241K | Sell |
2,173
-1,940
| -47% | -$215K | 0.07% | 79 |
|
|
2025
Q1 | $461K | Sell |
4,113
-855
| -17% | -$95.8K | 0.15% | 55 |
|
|
2024
Q4 | $459K | Sell |
4,968
-2,184
| -31% | -$202K | 0.15% | 57 |
|
|
2024
Q3 | $600K | Sell |
7,152
-435
| -6% | -$36.5K | 0.21% | 53 |
|
|
2024
Q2 | $521K | Sell |
7,587
-3,221
| -30% | -$221K | 0.19% | 54 |
|
|
2024
Q1 | $792K | Buy |
10,808
+9,929
| +1,130% | +$727K | 0.32% | 44 |
|
|
2023
Q4 | $71.2K | Hold |
879
| – | – | 0.03% | 138 |
|
|
2023
Q3 | $65.9K | Sell |
879
-151
| -15% | -$11.3K | 0.03% | 138 |
|
|
2023
Q2 | $79.4K | Buy |
1,030
+1
| +0.1% | +$77 | 0.04% | 128 |
|
|
2023
Q1 | $85.3K | Sell |
1,029
-123
| -11% | -$10.2K | 0.05% | 122 |
|
|
2022
Q4 | $98.9K | Buy |
1,152
+1
| +0.1% | +$86 | 0.06% | 121 |
|
|
2022
Q3 | $71K | Buy |
1,151
+2
| +0.2% | +$123 | 0.04% | 142 |
|
|
2022
Q2 | $71K | Buy |
1,149
+1
| +0.1% | +$62 | 0.04% | 147 |
|
|
2022
Q1 | $68K | Sell |
1,148
-192
| -14% | -$11.4K | 0.03% | 165 |
|
|
2021
Q4 | $97K | Sell |
1,340
-48
| -3% | -$3.48K | 0.04% | 146 |
|
|
2021
Q3 | $97K | Buy |
1,388
+1
| +0.1% | +$70 | 0.05% | 137 |
|
|
2021
Q2 | $96K | Buy |
+1,387
| New | +$96K | 0.05% | 142 |
|
|
2020
Q2 | – | Sell |
-3,838
| Closed | -$287K | – | 86 |
|
|
2020
Q1 | $287K | Sell |
3,838
-2,732
| -42% | -$204K | 0.27% | 58 |
|
|
2019
Q4 | $427K | Sell |
6,570
-12,157
| -65% | -$790K | 0.3% | 67 |
|
|
2019
Q3 | $1.19M | Buy |
+18,727
| New | +$1.19M | 0.88% | 41 |
|